{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:45:38Z","timestamp":1790027138819,"version":"4.0.1"},"reference-count":180,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Angiol"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This article deals with the role of c-reactive protein (CRP) in the development of atherosclerosis and its treatment. CRP has a predictive value in ischemic heart disease, restenosis, coronary artery disease, aortic atherosclerosis, and cerebrovascular disease. This article deals with the synthesis and mechanism of CRP-induced atherosclerosis and its treatment. CRP increases the formation of numerous atherogenic biomolecules such as reactive oxygen species (ROS), cytokines (interleukin [IL]-1\u03b2 and IL-6), cell adhesion molecules (intercellular adhesion molecule-1, vascular cell adhesion molecule-1, monocyte chemoattractant protein-1, activated complement C5, monocyte colony-stimulating factor, and numerous growth factors [insulin-like growth factor, platelet-derived growth factor, and transforming growth factor-\u03b2]). ROS mildly oxidizes low-density lipoprotein (LDL)-cholesterol to form minimally modified LDL which is further oxidized to form oxidized LDL. The above atherogenic biomolecules are involved in the development of atherosclerosis and has been described in detail in the text. This paper also deals with the treatment modalities for CRP-induced atherosclerosis which includes lipid-lowering drugs, antihypertensive drugs, antioxidants, aspirin, antidiabetic drugs, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, regular physical activity, weight reduction, and stoppage of cigarette smoking. In conclusion, CRP induces atherosclerosis through increases in atherogenic biomolecules and the treatment modalities would prevent, regress, and slow the progression of CRP-induced atherosclerosis.<\/jats:p>","DOI":"10.1055\/s-0044-1788296","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T23:04:45Z","timestamp":1721343885000},"page":"271-281","source":"Crossref","is-referenced-by-count":7,"title":["Role of C-Reactive Protein, An Inflammatory Biomarker in The Development of Atherosclerosis and Its Treatment"],"prefix":"10.1055","volume":"33","author":[{"given":"Kailash","family":"Prasad","sequence":"additional","affiliation":[{"name":"Department of Physiology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"issue":"06","key":"ref1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.31083\/j.rcm2306212","article-title":"Mechanism of hypercholesterolemia-induced atherosclerosis","volume":"23","author":"K Prasad","year":"2022","journal-title":"Rev Cardiovasc Med"},{"issue":"14","key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20143561","article-title":"The atherogenic role of circulating modified lipids in atherosclerosis","volume":"20","author":"V I Summerhill","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"4258","key":"ref3","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.822515","article-title":"Hyperlipidemia and atherosclerosis","volume":"193","author":"R Ross","year":"1976","journal-title":"Science"},{"issue":"22","key":"ref4","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.3889\/oamjms.2019.526","article-title":"Atherosclerosis prediction with high sensitivity C-reactive protein (hs-CRP) and related risk factor in patient with dyslipidemia","volume":"7","author":"D A Swastini","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"589654","DOI":"10.3389\/fimmu.2020.589654","article-title":"Targeting IL-1\u03b2 in the treatment of atherosclerosis","volume":"11","author":"W Mai","year":"2020","journal-title":"Front Immunol"},{"issue":"15","key":"ref6","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","article-title":"Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men","volume":"101","author":"P M Ridker","year":"2000","journal-title":"Circulation"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2249.2000.01281.x","article-title":"Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis","volume":"121","author":"H Bruunsgaard","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00547-003-1018-y","article-title":"C-reactive protein and cardiovascular diseases","volume":"12","author":"K Prasad","year":"2003","journal-title":"Int J Angiol"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejim.2007.04.026","article-title":"The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease","volume":"19","author":"F Karadag","year":"2008","journal-title":"Eur J Intern Med"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"12171","DOI":"10.1038\/s41598-023-39051-3","article-title":"Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population","volume":"13","author":"S Cederstr\u00f6m","year":"2023","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ehj.2014.11.005","article-title":"C-reactive protein, inflammation and coronary heart disease","volume":"67","author":"A K Shrivastava","year":"2015","journal-title":"Egypt Heart J"},{"issue":"09","key":"ref12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.98.9.839","article-title":"Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels","volume":"98","author":"P M Ridker","year":"1998","journal-title":"Circulation"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/vhrm.2006.2.3.221","article-title":"Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease","volume":"2","author":"R Osman","year":"2006","journal-title":"Vasc Health Risk Manag"},{"issue":"03","key":"ref14","first-page":"164","article-title":"Clinical use of C-reactive protein for the prognostic stratification of patients with ischemic heart disease","volume":"2","author":"L M Biasucci","year":"2001","journal-title":"Ital Heart J"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ahj.2007.04.060","article-title":"Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension","volume":"154","author":"A Shankar","year":"2007","journal-title":"Am Heart J"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1161\/01.STR.0000044168.00485.02","article-title":"C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study","volume":"33","author":"I M Van Der Meer","year":"2002","journal-title":"Stroke"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1586\/erc.11.159","article-title":"Role of C-reactive protein in cerebrovascular disease: a critical review","volume":"9","author":"M Di Napoli","year":"2011","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"16","key":"ref18","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1001\/archinte.164.16.1781","article-title":"C-reactive protein and atherosclerosis of the thoracic aorta: a population-based transesophageal echocardiographic study","volume":"164","author":"Y Agmon","year":"2004","journal-title":"Arch Intern Med"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0025-7125(05)70211-X","article-title":"C-reactive protein, inflammation, and coronary risk","volume":"84","author":"D A Morrow","year":"2000","journal-title":"Med Clin North Am"},{"issue":"19","key":"ref20","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1001\/jama.285.19.2481","article-title":"Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease","volume":"285","author":"P M Ridker","year":"2001","journal-title":"JAMA"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"P MJ Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-reactive protein at sites of inflammation and infection","volume":"9","author":"N R Sproston","year":"2018","journal-title":"Front Immunol"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.4049\/jimmunol.160.11.5294","article-title":"Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice","volume":"160","author":"A J Szalai","year":"1998","journal-title":"J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.molimm.2022.04.003","article-title":"IL-6 regulates induction of C-reactive protein gene expression by activating STAT3 isoforms","volume":"146","author":"D N Ngwa","year":"2022","journal-title":"Mol Immunol"},{"issue":"04","key":"ref25","first-page":"E720","article-title":"Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes","volume":"273","author":"S J Wigmore","year":"1997","journal-title":"Am J Physiol"},{"issue":"16","key":"ref26","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/01.CIR.0000096055.62724.C5","article-title":"Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells","volume":"108","author":"P Calabr\u00f3","year":"2003","journal-title":"Circulation"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jacc.2007.06.012","article-title":"C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk","volume":"50","author":"F G Hage","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"03","key":"ref28","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0021-9150(00)00586-4","article-title":"Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study","volume":"154","author":"J S Pankow","year":"2001","journal-title":"Atherosclerosis"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/gme.0b013e3181e750dd","article-title":"Oral postmenopausal hormone therapy, C-reactive protein, and cardiovascular outcomes","volume":"18","author":"E G Kurtz","year":"2011","journal-title":"Menopause"},{"issue":"07","key":"ref30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/01.CIR.100.7.713","article-title":"Hormone replacement therapy and increased plasma concentration of C-reactive protein","volume":"100","author":"P M Ridker","year":"1999","journal-title":"Circulation"},{"issue":"01","key":"ref31","first-page":"124","article-title":"Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive protein","volume":"90","author":"K Lacut","year":"2003","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref32","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0735-1097(03)00156-6","article-title":"Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women","volume":"41","author":"W Vongpatanasin","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/13697137.2014.940309","article-title":"Low-dose oral or non-oral hormone therapy: effects on C-reactive protein and atrial natriuretic peptide in menopause","volume":"18","author":"G Casanova","year":"2015","journal-title":"Climacteric"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0008-6363(02)00515-1","article-title":"Dietary cholesterol withdrawal reduces vascular inflammation and induces coronary plaque stabilization in miniature pigs","volume":"56","author":"P Verhamme","year":"2002","journal-title":"Cardiovasc Res"},{"issue":"23","key":"ref35","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1161\/CIRCULATIONAHA.104.506188","article-title":"Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects","volume":"111","author":"L R Tannock","year":"2005","journal-title":"Circulation"},{"issue":"09","key":"ref36","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.CIR.103.9.1191","article-title":"Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia","volume":"103","author":"P M Ridker","year":"2001","journal-title":"Circulation"},{"issue":"05","key":"ref37","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1067\/mva.2002.128301","article-title":"Serum lipids act as inverse acute phase reactants and are falsely low in patients with critical limb ischemia","volume":"36","author":"J Bismuth","year":"2002","journal-title":"J Vasc Surg"},{"issue":"03","key":"ref38","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/hy0302.104670","article-title":"Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and C-reacting protein","volume":"39","author":"K Yasunari","year":"2002","journal-title":"Hypertension"},{"issue":"05","key":"ref39","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1203\/00006450-199605000-00017","article-title":"Neutrophil respiratory burst in term and preterm neonates without signs of infection and in those with increased levels of C-reactive protein","volume":"39","author":"P Gessler","year":"1996","journal-title":"Pediatr Res"},{"issue":"03","key":"ref40","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/107424840400900308","article-title":"C-reactive protein increases oxygen radical generation by neutrophils","volume":"9","author":"K Prasad","year":"2004","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"01","key":"ref41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2005.01.057","article-title":"C-reactive protein induces VCAM-1 gene expression through NF-kappa B activation in vascular endothelial cells","volume":"185","author":"D Kawanami","year":"2006","journal-title":"Atherosclerosis"},{"issue":"18","key":"ref42","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","article-title":"Direct proinflammatory effect of C-reactive protein on human endothelial cells","volume":"102","author":"V Pasceri","year":"2000","journal-title":"Circulation"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00001721-200306000-00003","article-title":"Effects of C-reactive protein on the release of von Willebrand factor, E-selectin, thrombomodulin and intercellular adhesion molecule-1 from human umbilical vein endothelial cells","volume":"14","author":"A D Blann","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0162-3109(99)00007-7","article-title":"Regulation of complement activation by C-reactive protein","volume":"42","author":"C Mold","year":"1999","journal-title":"Immunopharmacology"},{"issue":"10","key":"ref45","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/jcmm.12357","article-title":"Complement factor C5a induces atherosclerotic plaque disruptions","volume":"18","author":"A Wezel","year":"2014","journal-title":"J Cell Mol Med"},{"issue":"04","key":"ref46","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1160\/TH14-12-1075","article-title":"Atheroprotective role of C5ar2 deficiency in apolipoprotein E-deficient mice","volume":"114","author":"J Selle","year":"2015","journal-title":"Thromb Haemost"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2022.03.014","article-title":"The multifaceted impact of complement on atherosclerosis","volume":"351","author":"M G Kiss","year":"2022","journal-title":"Atherosclerosis"},{"issue":"21","key":"ref48","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/01.CIR.103.21.2531","article-title":"Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs","volume":"103","author":"V Pasceri","year":"2001","journal-title":"Circulation"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"I1","DOI":"10.1002\/clc.4960141302","article-title":"The pathogenesis of atherosclerosis: an overview","volume":"14","author":"C J Schwartz","year":"1991","journal-title":"Clin Cardiol"},{"issue":"08","key":"ref50","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.4049\/jimmunol.148.8.2423","article-title":"Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes","volume":"148","author":"Y Jiang","year":"1992","journal-title":"J Immunol"},{"issue":"30","key":"ref51","doi-asserted-by":"crossref","first-page":"17779","DOI":"10.1074\/jbc.271.30.17779","article-title":"Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors","volume":"271","author":"M Gharaee-Kermani","year":"1996","journal-title":"J Biol Chem"},{"issue":"03","key":"ref52","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.510270314","article-title":"Monocyte chemoattractant protein-1 enhances expression of intercellular adhesion molecule-1 following ischemia-reperfusion of the liver in rats","volume":"27","author":"Y Yamaguchi","year":"1998","journal-title":"Hepatology"},{"issue":"06","key":"ref53","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1042\/CS20040315","article-title":"Inhibitory effect of pitavastatin (NK-104) on the C-reactive-protein-induced interleukin-8 production in human aortic endothelial cells","volume":"108","author":"E Kibayashi","year":"2005","journal-title":"Clin Sci (Lond)"},{"issue":"21","key":"ref54","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1161\/01.CIR.0000131160.94926.6E","article-title":"C-reactive protein promotes monocyte chemoattractant protein-1-mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes","volume":"109","author":"K H Han","year":"2004","journal-title":"Circulation"},{"issue":"08","key":"ref55","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.CIR.0000029802.88087.5E","article-title":"A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis","volume":"106","author":"S Verma","year":"2002","journal-title":"Circulation"},{"issue":"23","key":"ref56","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.4161\/cc.8.23.10068","article-title":"C-reactive protein: how conformational changes influence inflammatory properties","volume":"8","author":"S U Eisenhardt","year":"2009","journal-title":"Cell Cycle"},{"issue":"01","key":"ref57","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2005.03.031","article-title":"Native pentameric C-reactive protein displays more potent pro-atherogenic activities in human aortic endothelial cells than modified C-reactive protein","volume":"184","author":"S Devaraj","year":"2006","journal-title":"Atherosclerosis"},{"issue":"12","key":"ref58","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/01.CIR.0000033116.22237.F9","article-title":"Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells","volume":"106","author":"S K Venugopal","year":"2002","journal-title":"Circulation"},{"issue":"06","key":"ref59","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"S L Deshmane","year":"2009","journal-title":"J Interferon Cytokine Res"},{"issue":"07","key":"ref60","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","article-title":"RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"M A Hofmann","year":"1999","journal-title":"Cell"},{"issue":"01","key":"ref61","doi-asserted-by":"crossref","first-page":"13464","DOI":"10.1038\/s41598-021-92941-2","article-title":"Activation of NF-\u03baB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2","volume":"11","author":"C M Su","year":"2021","journal-title":"Sci Rep"},{"issue":"06","key":"ref62","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0090-6980(87)90120-1","article-title":"Effect of platelet-activating factor (PAF-acether) and its specific receptor antagonist, BN 52021, on interleukin 1 (IL1) release and synthesis by rat spleen adherent monocytes","volume":"33","author":"B Pignol","year":"1987","journal-title":"Prostaglandins"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000234772","article-title":"Effect of platelet-activating factor on monocyte activation and production of tumor necrosis factor","volume":"88","author":"B Bonavida","year":"1989","journal-title":"Int Arch Allergy Appl Immunol"},{"issue":"08","key":"ref64","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/MCA.0b013e32834c751f","article-title":"Elevated soluble receptor for advanced glycation end product levels in patients with acute coronary syndrome and positive cardiac troponin I","volume":"22","author":"G Basta","year":"2011","journal-title":"Coron Artery Dis"},{"issue":"01","key":"ref65","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1359-6101(98)00024-0","article-title":"Cytokine regulation of cellular adhesion molecule expression in inflammation","volume":"10","author":"A Meager","year":"1999","journal-title":"Cytokine Growth Factor Rev"},{"issue":"12","key":"ref66","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1161\/01.ATV.17.12.3570","article-title":"Reactive oxygen species are involved in shear stress-induced intercellular adhesion molecule-1 expression in endothelial cells","volume":"17","author":"J J Chiu","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"09","key":"ref67","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1182\/blood.V83.9.2669.2669","article-title":"Reactive oxygen species rapidly increase endothelial ICAM-1 ability to bind neutrophils without detectable upregulation","volume":"83","author":"H Sellak","year":"1994","journal-title":"Blood"},{"issue":"06","key":"ref68","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1089\/ars.2010.3522","article-title":"Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants","volume":"15","author":"J M Cook-Mills","year":"2011","journal-title":"Antioxid Redox Signal"},{"issue":"05","key":"ref69","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.bbamcr.2008.01.004","article-title":"Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells","volume":"1783","author":"S R Kim","year":"2008","journal-title":"Biochim Biophys Acta"},{"issue":"03","key":"ref70","first-page":"L533","article-title":"E-selectin expression in human endothelial cells by TNF-alpha-induced oxidant generation and NF-kappaB activation","volume":"275","author":"A Rahman","year":"1998","journal-title":"Am J Physiol"},{"issue":"01","key":"ref71","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0008-6363(96)00179-4","article-title":"Reactive oxygen species stimulate insulin-like growth factor I synthesis in vascular smooth muscle cells","volume":"33","author":"P Delafontaine","year":"1997","journal-title":"Cardiovasc Res"},{"issue":"24","key":"ref72","doi-asserted-by":"crossref","first-page":"13181","DOI":"10.3390\/ijms222413181","article-title":"Correlation between oxidative stress and transforming growth factor-beta in cancers","volume":"22","author":"J Chung","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"03","key":"ref73","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/107424840300800308","article-title":"Effects of flaxseed oil on serum lipids and atherosclerosis in hypercholesterolemic rabbits","volume":"8","author":"P Lee","year":"2003","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"04","key":"ref74","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/0002-8703(93)90102-F","article-title":"Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E","volume":"125","author":"K Prasad","year":"1993","journal-title":"Am Heart J"},{"issue":"06","key":"ref75","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/01.CIR.85.6.2337","article-title":"Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland","volume":"85","author":"D Steinberg","year":"1992","journal-title":"Circulation"},{"issue":"02","key":"ref76","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.atherosclerosis.2006.07.034","article-title":"Suppression of hypercholesterolemic atherosclerosis by pentoxifylline and its mechanism","volume":"192","author":"K Prasad","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/978-1-60327-029-8_24","article-title":"Oxidized low-density lipoprotein","volume":"610","author":"S Parthasarathy","year":"2010","journal-title":"Methods Mol Biol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"613780","DOI":"10.3389\/fphar.2020.613780","article-title":"Overview of OxLDL and its impact on cardiovascular health: focus on atherosclerosis","volume":"11","author":"A V Poznyak","year":"2021","journal-title":"Front Pharmacol"},{"issue":"02","key":"ref79","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.atherosclerosis.2006.11.029","article-title":"Oxidized LDL specifically promotes the initiation of monocyte invasion during transendothelial migration with upregulated PECAM-1 and downregulated VE-cadherin on endothelial junctions","volume":"194","author":"K Hashimoto","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4612-1190-7_6","article-title":"Pathophysiology of atherosclerosis","volume":"295","author":"K Prasad","year":"2000","journal-title":"Textbook of Angiology."},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1024154704469","article-title":"Oxygen supply modulates MCP-1 release in monocytes from young and aged rats: decrease of MCP-1 transcription and translation is age-related","volume":"248","author":"M Reale","year":"2003","journal-title":"Mol Cell Biochem"},{"issue":"01","key":"ref82","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1634\/stemcells.18-1-65","article-title":"The role of MCP-1 in atherosclerosis","volume":"18","author":"J R Harrington","year":"2000","journal-title":"Stem Cells"},{"issue":"04","key":"ref83","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jlb.52.4.449","article-title":"C-reactive protein selectively enhances the intracellular generation of reactive oxygen products by IgG-stimulated monocytes and neutrophils","volume":"52","author":"J M Zeller","year":"1992","journal-title":"J Leukoc Biol"},{"issue":"02","key":"ref84","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/01.ATV.13.2.197","article-title":"An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium","volume":"13","author":"H Li","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-1-1","article-title":"How hyperglycemia promotes atherosclerosis: molecular mechanisms","volume":"1","author":"D Aronson","year":"2002","journal-title":"Cardiovasc Diabetol"},{"issue":"13","key":"ref86","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1073\/pnas.87.13.5134","article-title":"Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells","volume":"87","author":"S D Cushing","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"ref87","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1681\/ASN.V8101537","article-title":"Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein","volume":"8","author":"Y Wang","year":"1997","journal-title":"J Am Soc Nephrol"},{"issue":"03","key":"ref88","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/jth.13925","article-title":"Oxidized low-density lipoprotein in inflammation-driven thrombosis","volume":"16","author":"G Obermayer","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref89","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1073\/pnas.76.1.333","article-title":"Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition","volume":"76","author":"J L Goldstein","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref90","doi-asserted-by":"crossref","DOI":"10.5772\/59375","volume-title":"Role of oxidized LDL in Atherosclerosis","author":"E Leiva","year":"2015"},{"issue":"34","key":"ref91","doi-asserted-by":"crossref","first-page":"20963","DOI":"10.1074\/jbc.272.34.20963","article-title":"Low density lipoprotein oxidation and its pathobiological significance","volume":"272","author":"D Steinberg","year":"1997","journal-title":"J Biol Chem"},{"issue":"02","key":"ref92","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.ATV.3.2.149","article-title":"Enhanced macrophage degradation of biologically modified low density lipoprotein","volume":"3","author":"T Henriksen","year":"1983","journal-title":"Arteriosclerosis"},{"issue":"10","key":"ref93","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1177\/43.10.7560885","article-title":"Evidence of foam cell and cholesterol crystal formation in macrophages incubated with oxidized LDL by fluorescence and electron microscopy","volume":"43","author":"A M Klinkner","year":"1995","journal-title":"J Histochem Cytochem"},{"issue":"02","key":"ref94","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3892\/etm.2020.8840","article-title":"C-reactive protein and cardiovascular disease: from animal studies to the clinic (Review)","volume":"20","author":"Y Fu","year":"2020","journal-title":"Exp Ther Med"},{"issue":"05","key":"ref95","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/01.CIR.0000114526.50618.24","article-title":"C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"109","author":"A Paul","year":"2004","journal-title":"Circulation"},{"issue":"07","key":"ref96","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1161\/CIRCULATIONAHA.105.556530","article-title":"Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice","volume":"112","author":"S B Schwedler","year":"2005","journal-title":"Circulation"},{"issue":"04","key":"ref97","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0735-1097(01)01804-6","article-title":"C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina","volume":"39","author":"J S Zebrack","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"ref98","doi-asserted-by":"crossref","first-page":"297","DOI":"10.31083\/j.rcm2410297","article-title":"C-reactive protein in atherosclerosis\u2014more than a biomarker, but not just a culprit","volume":"24","author":"K Kirkg\u00f6z","year":"2023","journal-title":"Rev Cardiovasc Med"},{"issue":"01","key":"ref99","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.STR.32.1.133","article-title":"Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke","volume":"32","author":"M Di Napoli","year":"2001","journal-title":"Stroke"},{"issue":"02","key":"ref100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2796.2005.01514.x","article-title":"Prognostic role of C-reactive protein in very old patients with acute ischaemic stroke","volume":"258","author":"L Masotti","year":"2005","journal-title":"J Intern Med"},{"issue":"01","key":"ref101","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1527-3466.2006.00033.x","article-title":"C-reactive protein (CRP)-lowering agents","volume":"24","author":"K Prasad","year":"2006","journal-title":"Cardiovasc Drug Rev"},{"issue":"09","key":"ref102","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1210\/jc.2004-0820","article-title":"Non-HDL cholesterol level is reliable to be an early predictor for vascular inflammation in type 2 diabetes mellitus","volume":"89","author":"C Y Wang","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"8732360","DOI":"10.1155\/2022\/8732360","article-title":"Effect of statins on serum level of hs-CRP and CRP in patients with cardiovascular diseases: a systematic review and meta-analysis of randomized controlled trials","volume":"2022","author":"T Kandelouei","year":"2022","journal-title":"Mediators Inflamm"},{"issue":"12","key":"ref104","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1161\/01.CIR.0000029743.68247.31","article-title":"Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction","volume":"106","author":"J K Plenge","year":"2002","journal-title":"Circulation"},{"issue":"01","key":"ref105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa042000","article-title":"Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease","volume":"352","author":"S E Nissen","year":"2005","journal-title":"N Engl J Med"},{"issue":"03","key":"ref106","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.100.3.230","article-title":"Long-term effects of pravastatin on plasma concentration of C-reactive protein","volume":"100","author":"P M Ridker","year":"1999","journal-title":"Circulation"},{"issue":"01","key":"ref107","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0021-9150(03)00158-8","article-title":"Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levels","volume":"169","author":"T Takeda","year":"2003","journal-title":"Atherosclerosis"},{"issue":"9147","key":"ref108","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0140-6736(05)76154-7","article-title":"Effect of statins on C-reactive protein in patients with coronary artery disease","volume":"353","author":"T E Strandberg","year":"1999","journal-title":"Lancet"},{"issue":"10","key":"ref109","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/clc.4960261008","article-title":"Rapid effects of simvastatin on lipid profile and C-reactive protein in patients with hypercholesterolemia","volume":"26","author":"J J Li","year":"2003","journal-title":"Clin Cardiol"},{"issue":"08","key":"ref110","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2022.12138","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"328","author":"R Chou","year":"2022","journal-title":"JAMA"},{"issue":"21","key":"ref111","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"P M Ridker","year":"2008","journal-title":"N Engl J Med"},{"issue":"06","key":"ref112","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/01.ATV.0000163840.63685.0c","article-title":"Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins","volume":"25","author":"C Arnaud","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"05","key":"ref113","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jcct.2018.05.004","article-title":"Improvement in LDL is associated with decrease in non-calcified plaque volume on coronary CTA as measured by automated quantitative software","volume":"12","author":"B Tamarappoo","year":"2018","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"10","key":"ref114","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jcmg.2018.04.015","article-title":"Effects of statins on coronary atherosclerotic plaques: the PARADIGM study","volume":"11","author":"S-E Lee","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"19","key":"ref115","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1161\/01.CIR.0000068312.21969.C8","article-title":"Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial","volume":"107","author":"C M Ballantyne","year":"2003","journal-title":"Circulation"},{"issue":"10","key":"ref116","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0002-9149(02)02774-1","article-title":"Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia","volume":"90","author":"C Gagn\u00e9","year":"2002","journal-title":"Am J Cardiol"},{"issue":"03","key":"ref117","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1081\/ERC-200033541","article-title":"The effect of fenofibrate on the levels of high sensitivity C-reactive protein in dyslipidemic obese patients","volume":"30","author":"E Coban","year":"2004","journal-title":"Endocr Res"},{"issue":"06","key":"ref118","first-page":"526","article-title":"The effect of fenofibrate on serum paraoxonase activity and inflammatory markers in patients with combined hyperlipidemia","volume":"62","author":"D Yesilbursa","year":"2005","journal-title":"Kardiol Pol"},{"issue":"06","key":"ref119","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/01.fjc.0000211787.30034.0a","article-title":"Effects of fenofibrate on C-reactive protein levels in hypertriglyceridemic patients","volume":"47","author":"C J Kim","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"issue":"04","key":"ref120","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/jama.290.4.502","article-title":"Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein","volume":"290","author":"D J Jenkins","year":"2003","journal-title":"JAMA"},{"issue":"06","key":"ref121","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00019501-200409000-00006","article-title":"Association between C-reactive protein and hypertension in healthy middle-aged men and women","volume":"15","author":"L E Bautista","year":"2004","journal-title":"Coron Artery Dis"},{"issue":"03","key":"ref122","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.amjhyper.2006.08.006","article-title":"Antihypertensive medications and C-reactive protein in the multi-ethnic study of atherosclerosis","volume":"20","author":"W Palmas","year":"2007","journal-title":"Am J Hypertens"},{"issue":"04","key":"ref123","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0002-9343(01)01115-9","article-title":"Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease","volume":"112","author":"N P Jenkins","year":"2002","journal-title":"Am J Med"},{"issue":"01","key":"ref124","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000068449","article-title":"Early use of beta-blockers is associated with attenuation of serum C-reactive protein elevation and favorable short-term prognosis after acute myocardial infarction","volume":"99","author":"T Anzai","year":"2003","journal-title":"Cardiology"},{"issue":"06","key":"ref125","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.amjcard.2003.12.010","article-title":"Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure","volume":"93","author":"K E Joynt","year":"2004","journal-title":"Am J Cardiol"},{"issue":"04","key":"ref126","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/hc0402.102929","article-title":"Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1","volume":"105","author":"M Pahor","year":"2002","journal-title":"Circulation"},{"issue":"11","key":"ref127","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.jacc.2003.12.051","article-title":"Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy","volume":"43","author":"K Yasunari","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"01","key":"ref128","doi-asserted-by":"crossref","first-page":"17234","DOI":"10.1038\/s41598-020-73741-6","article-title":"The effect of vitamin E supplementation on selected inflammatory biomarkers in adults: a systematic review and meta-analysis of randomized clinical trials","volume":"10","author":"O Asbaghi","year":"2020","journal-title":"Sci Rep"},{"issue":"08","key":"ref129","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ejcn.2014.296","article-title":". Effect of vitamin E supplementation on serum C-reactive protein level: a meta-analysis of randomized controlled trial","volume":"69","author":"S Saboori","year":"2015","journal-title":"Eur J Clin Nutr"},{"issue":"08","key":"ref130","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.freeradbiomed.2004.01.018","article-title":"Vitamin E modulation of C-reactive protein in smokers with acute coronary syndromes","volume":"36","author":"R T Murphy","year":"2004","journal-title":"Free Radic Biol Med"},{"issue":"06","key":"ref131","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2337\/diacare.23.6.733","article-title":"Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes","volume":"23","author":"J E Upritchard","year":"2000","journal-title":"Diabetes Care"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"1290749","DOI":"10.3389\/fnut.2023.1290749","article-title":"The cross-sectional relationship between vitamin C and high-sensitivity C-reactive protein levels: insights from NHANES database","volume":"10","author":"N Ding","year":"2023","journal-title":"Front Nutr"},{"issue":"14","key":"ref133","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1161\/01.CIR.103.14.1863","article-title":"Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis","volume":"103","author":"M Langlois","year":"2001","journal-title":"Circulation"},{"issue":"01","key":"ref134","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.STR.0000105391.62306.2E","article-title":"Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke","volume":"35","author":"C S\u00e1nchez-Moreno","year":"2004","journal-title":"Stroke"},{"issue":"04","key":"ref135","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000363194","article-title":"Antioxidant status and the risk of elevated C-reactive protein 12 years later","volume":"65","author":"C Julia","year":"2014","journal-title":"Ann Nutr Metab"},{"issue":"11","key":"ref136","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1161\/01.ATV.0000242794.65541.02","article-title":"C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells","volume":"26","author":"H Fujii","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"02","key":"ref137","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2009.07.052","article-title":"Serum vitamin C concentration and hs-CRP level in middle-aged Japanese men and women","volume":"208","author":"Y Kubota","year":"2010","journal-title":"Atherosclerosis"},{"issue":"02","key":"ref138","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3329\/jhpn.v31i2.16382","article-title":"Prevalence and correlates of prenatal vitamin A deficiency in rural Sidama, Southern Ethiopia","volume":"31","author":"S G Gebreselassie","year":"2013","journal-title":"J Health Popul Nutr"},{"issue":"05","key":"ref139","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3961\/jpmph.15.042","article-title":"Interaction of vitamin D and smoking on inflammatory markers in the urban elderly","volume":"48","author":"H Lee","year":"2015","journal-title":"J Prev Med Public Health"},{"issue":"01","key":"ref140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/tcmj.tcmj_198_19","article-title":"Vitamin D, C-reactive protein, and oxidative stress markers in chronic obstructive pulmonary disease","volume":"33","author":"S Pandey","year":"2019","journal-title":"Tzu-Chi Med J"},{"issue":"08","key":"ref141","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0735-1097(01)01289-X","article-title":"Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay","volume":"37","author":"M Feldman","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"05","key":"ref142","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/S0735-1097(01)01130-5","article-title":"The effect of aspirin on C-reactive protein as a marker of risk in unstable angina","volume":"37","author":"S Kennon","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"08","key":"ref143","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.CIR.100.8.793","article-title":"Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin","volume":"100","author":"I Ikonomidis","year":"1999","journal-title":"Circulation"},{"issue":"11","key":"ref144","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1538-7836.2004.01017.x","article-title":"A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C-reactive protein following myocardial infarction: the CADET trial","volume":"2","author":"M Woodward","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref145","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.CIR.0000025403.20953.23","article-title":"Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus","volume":"106","author":"S M Haffner","year":"2002","journal-title":"Circulation"},{"issue":"01","key":"ref146","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2337\/diacare.26.1.172","article-title":"Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients","volume":"26","author":"A Raji","year":"2003","journal-title":"Diabetes Care"},{"issue":"01","key":"ref147","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"P M Ridker","year":"2005","journal-title":"N Engl J Med"},{"issue":"02","key":"ref148","doi-asserted-by":"crossref","first-page":"383","DOI":"10.12669\/pjms.35.2.645","article-title":"Effect of sitagliptin and glimepiride on C-reactive protein (CRP) in overweight Type-2 diabetic patients","volume":"35","author":"M Hussain","year":"2019","journal-title":"Pak J Med Sci"},{"issue":"12","key":"ref149","doi-asserted-by":"crossref","first-page":"107723","DOI":"10.1016\/j.jdiacomp.2020.107723","article-title":"Anti-inflammatory properties of antidiabetic drugs: a \u201cpromised land\u201d in the COVID-19 era?","volume":"34","author":"N Katsiki","year":"2020","journal-title":"J Diabetes Complications"},{"issue":"05","key":"ref150","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00392-005-0222-5","article-title":"Influence of the angiotensin converting enzyme inhibitor ramipril on high-sensitivity C-reactive protein (hs-CRP) in patients with documented atherosclerosis","volume":"94","author":"V Mitrovic","year":"2005","journal-title":"Z Kardiol"},{"issue":"08","key":"ref151","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1161\/HYPERTENSIONAHA.122.19312","article-title":"Effects of ramipril on biomarkers of endothelial dysfunction and inflammation in hypertensive children on maintenance hemodialysis: the SEARCH randomized placebo-controlled trial","volume":"79","author":"A M Ateya","year":"2022","journal-title":"Hypertension"},{"issue":"07","key":"ref152","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/01.CIR.103.7.919","article-title":"Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE)","volume":"103","author":"E Lonn","year":"2001","journal-title":"Circulation"},{"issue":"04","key":"ref153","first-page":"211","article-title":"Exploring the effects of ACE inhibitor tissue penetration on vascular inflammation following acute myocardial infarction","volume":"15","author":"J P Tsikouris","year":"2004","journal-title":"Coron Artery Dis"},{"issue":"06","key":"ref154","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1042\/CS20030127","article-title":"Synergistic effect of angiotensin-converting enzyme (ACE) and 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibition on inflammatory markers in atherosclerotic rabbits","volume":"105","author":"M P Oubi\u00f1a","year":"2003","journal-title":"Clin Sci (Lond)"},{"issue":"09","key":"ref155","first-page":"29","article-title":"[Effect of fosinopril on the rate of neurohumoral and proinflammatory activation in patients with heart failure]","volume":"82","author":"A E Berezin","year":"2004","journal-title":"Klin Med (Mosk)"},{"issue":"05","key":"ref156","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.clinthera.2005.05.006","article-title":"Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study","volume":"27","author":"L M Ruilope","year":"2005","journal-title":"Clin Ther"},{"issue":"09","key":"ref157","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1210\/jc.2002-021836","article-title":"Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action","volume":"88","author":"P Dandona","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"03","key":"ref158","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/hr.2009.212","article-title":"Candesartan effect on inflammation in hypertension","volume":"33","author":"G Derosa","year":"2010","journal-title":"Hypertens Res"},{"key":"ref159","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1475-2840-11-118","article-title":"Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure","volume":"11","author":"M Sakamoto","year":"2012","journal-title":"Cardiovasc Diabetol"},{"issue":"02","key":"ref160","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jacc.2004.03.065","article-title":"Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease","volume":"44","author":"B Schieffer","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"05","key":"ref161","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00001648-200209000-00012","article-title":"Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults","volume":"13","author":"E S Ford","year":"2002","journal-title":"Epidemiology"},{"issue":"08","key":"ref162","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1046\/j.1532-5415.2003.51380.x","article-title":"The associations between physical activity and inflammatory markers in high-functioning older persons: MacArthur studies of successful aging","volume":"51","author":"D B Reuben","year":"2003","journal-title":"J Am Geriatr Soc"},{"issue":"01","key":"ref163","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3329\/jhpn.v30i1.11278","article-title":"Physical inactivity is correlated with levels of quantitative C-reactive protein in serum, independent of obesity: results of the national surveillance of risk factors of non-communicable diseases in Iran","volume":"30","author":"A Esteghamati","year":"2012","journal-title":"J Health Popul Nutr"},{"issue":"11","key":"ref164","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s00421-014-2953-3","article-title":"Small-sided games training reduces CRP, IL-6 and leptin in sedentary, middle-aged men","volume":"114","author":"A E Mendham","year":"2014","journal-title":"Eur J Appl Physiol"},{"issue":"02","key":"ref165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.joca.2014.11.005","article-title":"Effects of total and regional fat loss on plasma CRP and IL-6 in overweight and obese, older adults with knee osteoarthritis","volume":"23","author":"K M Beavers","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"issue":"12","key":"ref166","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.jand.2013.07.004","article-title":"Diet quality is inversely associated with C-reactive protein levels in urban, low-income African-American and white adults","volume":"113","author":"M F Kuczmarski","year":"2013","journal-title":"J Acad Nutr Diet"},{"issue":"04","key":"ref167","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1210\/jc.2004-1011","article-title":"Diet-induced weight loss is associated with decreases in plasma serum amyloid a and C-reactive protein independent of dietary macronutrient composition in obese subjects","volume":"90","author":"K D O'Brien","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"ref168","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7326\/0003-4819-138-11-200306030-00010","article-title":"Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States","volume":"138","author":"L A Bazzano","year":"2003","journal-title":"Ann Intern Med"},{"issue":"06","key":"ref169","first-page":"437","article-title":"Relation between alcohol consumption and C-reactive protein levels in the adult US population","volume":"15","author":"S H Stewart","year":"2002","journal-title":"J Am Board Fam Pract"},{"key":"ref170","doi-asserted-by":"crossref","first-page":"3706508","DOI":"10.1155\/2022\/3706508","article-title":"Role of C-reactive protein in diabetic inflammation","volume":"2022","author":"J Stanimirovic","year":"2022","journal-title":"Mediators Inflamm"},{"issue":"01","key":"ref171","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1038\/s41598-019-40987-8","article-title":"Association of C-reactive protein with risk of developing type 2 diabetes mellitus, and role of obesity and hypertension: a large population-based Korean cohort study","volume":"9","author":"S Kanmani","year":"2019","journal-title":"Sci Rep"},{"issue":"11","key":"ref172","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.2337\/diacare.25.11.2016","article-title":"Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study","volume":"25","author":"T S Han","year":"2002","journal-title":"Diabetes Care"},{"issue":"01","key":"ref173","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcjd.2018.03.007","article-title":"Association between elevated c-reactive protein levels and prediabetes in adults, particularly impaired glucose tolerance","volume":"43","author":"K Kato","year":"2019","journal-title":"Can J Diabetes"},{"issue":"04","key":"ref174","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-0042-1756175","article-title":"Involvement of AGE and its receptors in the pathogenesis of hypertension in elderly people and its treatment","volume":"31","author":"K Prasad","year":"2022","journal-title":"Int J Angiol"},{"key":"ref175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1054-3589(08)60961-8","article-title":"Advanced glycosylation: chemistry, biology, and implications for diabetes and aging","volume":"23","author":"R Bucala","year":"1992","journal-title":"Adv Pharmacol"},{"key":"ref176","first-page":"1","volume-title":"AGE-RAGE stress in the pathophysiology of atherosclerosis and its treatment","author":"K Prasad","year":"2022"},{"issue":"02","key":"ref177","first-page":"341","article-title":"New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor","volume":"3","author":"F Montecucco","year":"2008","journal-title":"Clin Interv Aging"},{"issue":"7255","key":"ref178","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.321.7255.199","article-title":"Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses","volume":"321","author":"J Danesh","year":"2000","journal-title":"BMJ"},{"issue":"14","key":"ref179","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"J Danesh","year":"2004","journal-title":"N Engl J Med"},{"issue":"16","key":"ref180","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1161\/01.CIR.0000033819.29662.09","article-title":"Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals","volume":"106","author":"R Park","year":"2002","journal-title":"Circulation"}],"container-title":["International Journal of Angiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1788296.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T11:50:48Z","timestamp":1730807448000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1788296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":180,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2024,11,4]]},"published-print":{"date-parts":[[2024,12]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1788296","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1061-1711","1615-5939"],"issn-type":[{"value":"1061-1711","type":"print"},{"value":"1615-5939","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,18]]}}}